Jamal Rana MD FACC/LinkedIn
Nov 11, 2025, 23:38
The Wall Street Journal Features Major AHA Trials on Cholesterol Breakthroughs
Jamal Rana, Professor in the Department of Clinical Science at Kaiser Permanente Bernard J. Tyson School of Medicine, posted on LinkedIn:
”Many reached out requesting access to read the full article. The story made it to the print version, given this was The Wall Street Journal’s main coverage of the biggest trials presented at AHA Scientific Sessions 2025. We are now in era where multiple options exist to aggressively treat LDL cholesterol in high-risk patients to prevent heart disease.
Link here.”
Stay updated with Hemostasis Today.
AHA
American College of Cardiology
American Heart Association
Atherosclerosis
Betsy McKay
Cardiology
Cholesterol
European Atherosclerosis Society
Health
Heart Disease
Heart Health
Hematology
Hemostasis
Hemostasis Today
Jamal Rana
Kaiser Permanente Bernard J. Tyson School of Medicine
Medicine
The Wall Street Journal
thrombosis
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25
-
Jan 7, 2026, 05:04Heghine Khachatryan on VWD: A Landmark in the History of Hematology
-
Jan 6, 2026, 13:39JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
-
Jan 6, 2026, 10:10This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for 𝛃-Thalassaemia Patient at UCLH
-
Jan 6, 2026, 09:53Hamideh Yadegari: Coagulation–Inflammation Crosstalk: Mechanisms, Pathways, and Clinical Implications